SCHEMBL2908752

SCHEMBL2908752

Cc1cc2cccc(Nc3ccc4c(N)cccc4n3)c2o1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.39
ALDH1A1 P00352 4/20 0.38
GAA P10253 4/20 0.38
KDM4E B2RXH2 4/20 0.38
LMNA P02545 3/20 0.38
KMT2A Q03164 3/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
HPGD P15428 2/20 0.38
POLB P06746 2/20 0.38
GLA P06280 1/20 0.38
PTBP1 P26599 1/20 0.38
RCE1 Q9Y256 1/20 0.38
IGF1R P08069 1/20 0.38
DHFR P00374 1/20 0.38
EGFR P00533 1/20 0.37
KDR P35968 1/20 0.37
KDM1A O60341 1/20 0.36
MAPT P10636 4/20 0.36
HTT P42858 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2906630 0.83 ACP1 (0.40) SLC2A1ALDH1A1GAAKDM4ELMNA
SCHEMBL2904800 0.79 EGFR (0.50) SLC2A1ALDH1A1IGF1REGFRKDR
SCHEMBL2906707 0.78 MAPT (0.46) ALDH1A1GAAKDM4EKMT2AMAPT
SCHEMBL2901473 0.77 NTRK1 (0.42) SLC2A1ALDH1A1GAAKDM4EKMT2A
SCHEMBL2907882 0.76 POLB (0.44) ALDH1A1GAAKDM4ELMNAKMT2A
SCHEMBL2905387 0.76 RECQL (0.39) ALDH1A1GAAKDM4ELMNAKMT2A
SCHEMBL2906940 0.75 IGF1R (0.34) SLC2A1ALDH1A1GAAKDM4EHPGD
SCHEMBL2907955 0.75 ADRA1A (0.48) SLC2A1RAB9AIGF1RKDR
SCHEMBL2901732 0.74 EGFR (0.41) SLC2A1NPC1RAB9AIGF1REGFR
SCHEMBL2909328 0.74 NFKBIA (0.48) ALDH1A1LMNAKMT2AHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825253-B2 2-aminoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2010-11-02 US claimed
EP-2076495-B1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES HOFFMANN LA ROCHE (CH) 2010-08-18 EP claimed
EP-2076495-A1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES F.HOFFMANN-LA ROCHE AG (CH) 2009-07-08 EP claimed
WO-2008037626-A1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-03 WO claimed
US-20080081907-A1 2-AMINOQUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2008-04-03 US claimed
US-7825253-B2 2-aminoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2010-11-02 US disclosed
EP-2076495-B1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES HOFFMANN LA ROCHE (CH) 2010-08-18 EP disclosed
EP-2076495-A1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES F.HOFFMANN-LA ROCHE AG (CH) 2009-07-08 EP disclosed
WO-2008037626-A1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-03 WO disclosed
US-20080081907-A1 2-AMINOQUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2008-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081907-A1 2-AMINOQUINOLINE DERIVATIVES AR, ADRA2C, RCC2 SLC2A1 2068/4885ALDH1A1 872/4885GAA 3960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.